Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

The Pemphigus Disease Area Index and Autoimmune Bullous Skin Disorder Intensity Score are the best tools for assessing pemphigus severity.

COVID-19 reinfection may trigger alopecia areata.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Hair health depends on various factors and hair loss can significantly affect a person's well-being; understanding hair biology is key for creating effective hair care treatments.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Baricitinib is effective and safe for treating severe alopecia areata.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Mice with autoimmune hair loss showed signs of heart problems.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

The visfatin GT genotype may increase the risk of Alopecia Areata.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.